Mariotto, Sara
 Distribuzione geografica
Continente #
EU - Europa 5.655
NA - Nord America 5.065
AS - Asia 4.139
SA - Sud America 727
AF - Africa 124
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 15.741
Nazione #
US - Stati Uniti d'America 4.947
RU - Federazione Russa 2.935
SG - Singapore 1.684
CN - Cina 1.276
BR - Brasile 611
GB - Regno Unito 583
IT - Italia 505
HK - Hong Kong 403
DE - Germania 314
VN - Vietnam 311
SE - Svezia 301
FR - Francia 295
IE - Irlanda 295
FI - Finlandia 158
KR - Corea 131
CA - Canada 70
ID - Indonesia 59
AR - Argentina 56
JP - Giappone 51
IN - India 47
UA - Ucraina 42
PL - Polonia 40
ES - Italia 37
BE - Belgio 35
ZA - Sudafrica 34
MX - Messico 31
AT - Austria 29
NL - Olanda 29
TG - Togo 29
BD - Bangladesh 27
AU - Australia 25
BJ - Benin 25
TR - Turchia 25
IR - Iran 23
LT - Lituania 16
EC - Ecuador 15
IQ - Iraq 14
AE - Emirati Arabi Uniti 13
CL - Cile 11
VE - Venezuela 11
MA - Marocco 10
UZ - Uzbekistan 10
PK - Pakistan 9
SA - Arabia Saudita 8
CO - Colombia 7
IL - Israele 7
EG - Egitto 6
KE - Kenya 6
PY - Paraguay 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
PE - Perù 5
RO - Romania 5
JO - Giordania 4
LB - Libano 4
LU - Lussemburgo 4
OM - Oman 4
PA - Panama 4
TW - Taiwan 4
AZ - Azerbaigian 3
GR - Grecia 3
KZ - Kazakistan 3
NP - Nepal 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
ML - Mali 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GY - Guiana 1
Totale 15.728
Città #
Moscow 1.022
Singapore 737
Dallas 705
Chandler 689
Ashburn 618
Southend 414
Hong Kong 401
Beijing 292
Dublin 281
New York 163
Woodbridge 157
Verona 152
Los Angeles 144
Jacksonville 131
The Dalles 119
Ann Arbor 111
Lawrence 98
Princeton 98
Ho Chi Minh City 96
Wilmington 85
Helsinki 75
Munich 73
Jinan 71
Dearborn 66
Houston 66
Redondo Beach 62
Shenyang 55
Hanoi 54
Nanjing 53
Redmond 53
Sindelfingen 52
São Paulo 51
London 48
Buffalo 44
Columbus 43
Hebei 43
Santa Clara 43
Tianjin 42
Jakarta 41
Milan 39
Tokyo 39
Warsaw 38
Washington 38
Dong Ket 36
Brussels 34
Seattle 33
Seoul 33
Brooklyn 31
Lomé 29
Nuremberg 29
Guangzhou 28
Phoenix 28
Boardman 27
Changsha 27
Chicago 27
Denver 27
Montreal 27
Ningbo 27
Lappeenranta 26
Turku 26
Cotonou 25
Bologna 24
Zhengzhou 24
Hangzhou 23
Orem 23
Adelaide 22
Nanchang 22
Falls Church 21
Taiyuan 21
Belo Horizonte 20
Council Bluffs 20
Poplar 20
Haikou 18
Johannesburg 18
Kent 18
Toronto 18
Rio de Janeiro 17
Atlanta 16
Redwood City 16
Taizhou 16
Boston 15
Frankfurt am Main 15
Norwalk 15
Mexico City 14
Vienna 14
Bloomsbury 13
Falkenstein 13
Haiphong 13
Campinas 12
Chennai 12
Brasília 11
Fairfield 11
Hefei 11
Lanzhou 11
Menlo Park 11
Rome 11
San Francisco 11
Stockholm 11
Dongguan 10
Florence 10
Totale 8.843
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 225
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 209
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 204
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 200
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 200
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 200
Brentuximab vedotin: axonal microtubule's Apollyon 188
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 185
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 184
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 183
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 183
Time for a Consensus Conference on pain in neurorehabilitation 180
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 178
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 177
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 174
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 166
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 164
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 164
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 160
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 158
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 154
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 154
Nervous system: subclinical target of SARS-CoV-2 infection 152
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 152
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 147
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 147
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 146
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 143
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 143
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 139
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 138
Anti-MOG-associated demyelinating disorders: two sides of the same coin 138
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 137
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 136
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 131
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 130
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 130
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 129
Oligoclonal bands: clinical utility and interpretation cues 129
HCV-related nervous system disorders. 128
Gender disparity in editorial boards of journals in neurology 127
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 125
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 125
Inter-center agreement in the interpretation of oligoclonal bands 123
Autoimmune encephalitis misdiagnosis and mimics 122
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network 121
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 121
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 121
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 120
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 118
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 118
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 118
Is there a correlation between MOGAD and SARS-CoV-2 infection? 116
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 114
A score that predicts aquaporin-4-IgG positivity in patients with longitudinally extensive transverse myelitis 114
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 114
Peripheral neuropathy and central nervous system involvement in cryoglobulinenia. 113
Autoimmune encephalitis: a retrospective monocentric experience 112
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 111
l-dopa-induced off: functional overlay in Parkinson disease 110
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 110
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 108
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 108
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 107
Infectious neuropathies 107
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 107
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 105
Cerebrospinal fluid analysis and the determination of oligoclonal bands 105
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 104
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 100
HCV-related central and peripheral nervous system demyelinating disorders. 99
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 99
Exposure to TNF inhibitors is rare at MOGAD presentation 98
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 97
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 97
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 97
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 97
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 95
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 94
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 94
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 93
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 93
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 93
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 92
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 92
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 92
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 91
Diagnostics of dysimmune peripheral neuropathies 91
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 91
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 91
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 91
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease 90
Diagnostics of paraneoplastic neurological syndromes 90
Diagnostics of anti-MAG antibody polyneuropathy 89
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 88
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 88
Ophthalmoparesis mimicking myasthenia gravis as acute manifestation of Hashimoto’s encephalopathy 88
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 86
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 86
Investigating the association between neoplasms and MOG antibody-associated disease 86
Totale 12.677
Categoria #
all - tutte 59.841
article - articoli 58.351
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 390
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.100
Totale 119.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021304 0 0 0 0 0 61 28 18 45 10 73 69
2021/2022864 57 266 2 119 19 32 15 37 32 37 71 177
2022/20231.939 115 188 160 343 141 470 25 131 232 33 63 38
2023/20241.279 47 82 137 136 112 304 56 76 21 71 167 70
2024/20253.180 149 198 120 493 155 117 188 199 534 245 258 524
2025/20266.713 647 675 639 1.612 2.775 365 0 0 0 0 0 0
Totale 16.021